KERA anticorps (AA 21-352)
-
- Antigène Voir toutes KERA Anticorps
- KERA (Keratocan (KERA))
-
Épitope
- AA 21-352
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp KERA est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Réactivité croisée
- Humain
- Purification
- Antigen Affinity Purified
- Immunogène
- Recombinant Human Keratocan protein (21-352AA)
- Isotype
- IgG
- Top Product
- Discover our top product KERA Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- KERA (Keratocan (KERA))
- Autre désignation
- KERA (KERA Produits)
- Synonymes
- anticorps KERA, anticorps si:dkeyp-38g8.3, anticorps zgc:136259, anticorps CNA2, anticorps SLRR2B, anticorps keratocan, anticorps KERA, anticorps kera, anticorps Kera
- Sujet
-
Background: May be important in developing and maintaining corneal transparency and for the structure of the stromal matrix.
Aliases: CNA2 antibody, KERA antibody, KERA_HUMAN antibody, Keratan sulfate proteoglycan keratocan antibody, Keratocan antibody, KTN antibody, SLRR2B antibody
- UniProt
- O60938
- Pathways
- Glycosaminoglycan Metabolic Process
-